• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Aquatech Acquires Koch's Direct Lithium Extraction Business, Integrating Li-Pro™ DLE into the PEARL™ Technology Platform

    9/16/25 5:21:00 PM ET
    $A
    $EQNR
    $SLI
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Integrated oil Companies
    Energy
    Get the next $A alert in real time by email

    CANONSBURG, Pa., Sept. 16, 2025 /PRNewswire/ -- Aquatech has acquired Koch Technology Solutions' (KTS) direct lithium extraction (DLE) business, integrating the Li-Pro™ Lithium Selective Sorption (LSS) technology and extensive Li-Pro IP portfolio into the PEARL™ process technology platform.

    Aquatech and Koch logos

    The acquisition of KTS' Li-Pro LSS technology adds direct lithium extraction to Aquatech's extensive process flowsheet IP, lithium conversion and crystallization capabilities. With this addition, Aquatech's PEARL platform becomes the only commercially proven, end-to-end flowsheet solution for lithium processing. Spanning lithium extraction, purification and refining, the PEARL process technology platform delivers high-purity battery materials for electric vehicles (EV) and utility-scale electricity storage systems (ESS).

    The integration and optimization of upstream and downstream lithium processing will empower lithium resource owners with modularized process solutions at scale. This approach improves project bankability by removing process risk, accelerating project schedules and reducing the total cost of lithium production. Li-Pro LSS will be available under technology license as part of the PEARL full flowsheet licensing offerings.

    As part of the acquisition, all ongoing lithium extraction projects utilizing Li-Pro technology and associated licenses, agreements and performance guarantees will be transferred to Aquatech. This includes KTS' role in the Joint Development Agreement (JDA) with Standard Lithium Ltd. (TSXV:SLI) (NYSE:A) in the Smackover Formation, where they have completed over 12,000 operational cycles using Li-Pro technology at their demonstration plant and achieved an average lithium recovery of over 95%. It also includes a licensing agreement with Smackover Lithium, a joint venture between Standard Lithium and Equinor (NYSE:EQNR) (OSE:EQNR), for the first phase of its South West Arkansas project. The project is among the largest lithium projects in the US, with an initial phase of 22,500 tons per annum (tpa) of lithium carbonate equivalent targeting first production in 2028, with significant scope for future expansion.

    "Koch Technology Solutions has proven the Li-Pro LSS technology as a successful DLE solution, and the time has come to scale it for the market. Aquatech is uniquely placed to scale this technology and deliver it into projects as a cost competitive, end-to-end process solution, creating significant value for the lithium industry," commented Dave Dotson, President at Koch Engineered Solutions, the parent company of KTS.

    "We are confident that our legacy lithium customers will benefit from the broader offering of Aquatech. More broadly, Koch continues to maintain an active interest in the success of the technology via its investments in several key companies within the lithium minerals and lithium battery industries," said Garrett Krall, Critical Minerals & Lithium Business Leader at Koch Technology Solutions. 

     "Fragmented technology offerings increase project cost, risk and time-to-market, which has hindered the ramp-up of urgently needed critical minerals production in the Americas and Europe. Bringing Li-Pro into the PEARL technology platform solves this pressing industry need by offering the only proven full flowsheet solution that encompasses both upstream and downstream lithium processing technology," commented Venkee Sharma, Executive Chairman at Aquatech.

    Mr. Sharma continued, "We welcome the KTS Li-Pro team to Aquatech and commend them on the pioneering work done to develop Li-Pro LSS. With over 45 years of experience scaling commercially proven technologies, we are excited to evolve Li-Pro LSS both as a standalone technology offering and as part of the PEARL platform."

    About Aquatech

    Aquatech leverages innovative technology, engineering and execution leadership to solve the world's most demanding process challenges in lithium, critical minerals and industrial water. Aquatech's technology portfolio, project execution and service capabilities are grounded in a culture of performance excellence built up over four decades, with thousands of facilities using our solutions in over 60 countries.

    www.aquatech.com

    About Koch Technology Solutions

    Koch Technology Solutions (KTS) is a leader in technology licensing, delivering operating efficiency and capital productivity for licensees deploying the technologies in our portfolio. KTS partners with companies developing chemical process technologies to create attractive licensing solutions for commercial deployment, helping to bring the next generation of process technologies to the market.

    www.kochtechsolutions.com

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/aquatech-acquires-kochs-direct-lithium-extraction-business-integrating-li-pro-dle-into-the-pearl-technology-platform-302558347.html

    SOURCE Aquatech

    Get the next $A alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $A
    $EQNR
    $SLI

    CompanyDatePrice TargetRatingAnalyst
    Equinor ASA
    $EQNR
    3/24/2026$40.40Underweight → Equal-Weight
    Morgan Stanley
    Equinor ASA
    $EQNR
    3/20/2026Sell → Neutral
    UBS
    Equinor ASA
    $EQNR
    2/5/2026$22.00 → $25.00Hold
    TD Cowen
    Equinor ASA
    $EQNR
    2/5/2026Buy → Neutral
    BofA Securities
    Agilent Technologies Inc.
    $A
    1/20/2026$180.00Buy
    HSBC Securities
    Equinor ASA
    $EQNR
    1/8/2026Hold
    Jefferies
    Agilent Technologies Inc.
    $A
    1/5/2026$160.00In-line → Outperform
    Evercore ISI
    Agilent Technologies Inc.
    $A
    12/15/2025$165.00Equal Weight → Overweight
    Barclays
    More analyst ratings

    $A
    $EQNR
    $SLI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Equinor upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Equinor from Underweight to Equal-Weight and set a new price target of $40.40

    3/24/26 1:44:44 PM ET
    $EQNR
    Integrated oil Companies
    Energy

    Equinor upgraded by UBS

    UBS upgraded Equinor from Sell to Neutral

    3/20/26 8:28:40 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    TD Cowen reiterated coverage on Equinor with a new price target

    TD Cowen reiterated coverage of Equinor with a rating of Hold and set a new price target of $25.00 from $22.00 previously

    2/5/26 7:02:53 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    $A
    $EQNR
    $SLI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Agilent Announces the BioTek Cytation 9 Cell Imaging Multimode Reader

    Agilent Technologies, Inc. (NYSE:A) today announced the launch of the BioTek Cytation 9 cell imaging multimode reader, the newest addition to the Cytation portfolio combining multimode microplate reading and high-content cell imaging in a single platform. Building on a decade of Cytation innovation and shaped by continuous customer feedback, the BioTek Cytation 9 helps laboratories move from samples to insights faster, supporting workflows from basic research through high‑content screening. Designed for researchers running both cell-based and biochemical assays, Cytation 9 brings expanded imaging capabilities along with advanced hybrid microplate detection technologies. Key features inc

    4/1/26 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Buffalo Potash Bolsters Board with Appointment of Jeff Barber as Disley Project Advances

    Saskatoon, Saskatchewan--(Newsfile Corp. - March 31, 2026) - Buffalo Potash Corporation (TSXV: BUFF) (OTCQB:BLPTF) (the "Company" or "Buffalo") is pleased to announce the appointment of Jeff Barber as a Director to the Company's Board of Directors, effective March 26, 2026. Jeff Barber brings over two decades of experience in investment banking, M&A advisory, and corporate finance with a track record of supporting resource companies through transformative stages of growth. Mr. Barber has served as an Independent Director of Standard Lithium Ltd. (NYSE:SLI) since 2017, a period during which the company transitioned from an early-stage TSXV explorer to its current position as a leading near-c

    3/31/26 7:00:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    Standard Lithium Reports Fourth Quarter and Full Year 2025 Results

    Signed First Binding Customer Offtake Agreement with TrafiguraReceived Indications of Interest for Over $1 Billion in Project FinanceProvides an Update on Plans for a Final Investment Decision ("FID") on the South West Arkansas Project (the "SWA Project") VANCOUVER, British Columbia, March 30, 2026 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE.A: SLI), a leading near-commercial lithium company, today announced its financial and operating results for the three-month and full year periods ended December 31, 2025. "We had a busy and productive fourth quarter as we advanced and completed multiple important milestones and deliverables for the

    3/30/26 8:00:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    $A
    $EQNR
    $SLI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Henson Meghan

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    4/2/26 4:06:44 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Rataj Sue H.

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    3/23/26 4:39:21 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 4 filed by Brawley Otis W

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    3/23/26 4:36:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Gonsalves Rodney (Amendment)

    4/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    10/20/23 1:07:25 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    9/29/23 4:03:46 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $A
    $EQNR
    $SLI
    SEC Filings

    View All

    Agilent Technologies Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    4/3/26 4:05:10 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 6-K filed by Equinor ASA

    6-K - EQUINOR ASA (0001140625) (Filer)

    4/1/26 8:10:05 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    SEC Form 6-K filed by Equinor ASA

    6-K - EQUINOR ASA (0001140625) (Filer)

    3/31/26 6:05:05 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    $A
    $EQNR
    $SLI
    Leadership Updates

    Live Leadership Updates

    View All

    Buffalo Potash Bolsters Board with Appointment of Jeff Barber as Disley Project Advances

    Saskatoon, Saskatchewan--(Newsfile Corp. - March 31, 2026) - Buffalo Potash Corporation (TSXV: BUFF) (OTCQB:BLPTF) (the "Company" or "Buffalo") is pleased to announce the appointment of Jeff Barber as a Director to the Company's Board of Directors, effective March 26, 2026. Jeff Barber brings over two decades of experience in investment banking, M&A advisory, and corporate finance with a track record of supporting resource companies through transformative stages of growth. Mr. Barber has served as an Independent Director of Standard Lithium Ltd. (NYSE:SLI) since 2017, a period during which the company transitioned from an early-stage TSXV explorer to its current position as a leading near-c

    3/31/26 7:00:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    Agilent Names Adam S. Elinoff as Chief Financial Officer

    Agilent Technologies Inc. (NYSE:A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027719923/en/Adam S. Elinoff, Chief Financial Officer, Agilent Technologies Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving enterprise-wide transformations, optimizing financial operations and scaling global capabilities. He joins Agilent from Amgen, a worldwide pioneer in biotechnology, where he advanced through a series of

    10/27/25 4:15:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Standard Lithium Expands Leadership Team with Appointment of General Counsel

    VANCOUVER, British Columbia, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE:SLI), a leading near-commercial lithium company, is announcing the appointment of Michael Lutgring as General Counsel, effective August 18, 2025. "We are excited to have Michael join our senior leadership team," said David Park, Chief Executive Officer and Director of Standard Lithium. "Michael's deep and wide-ranging experience will be critical as we strengthen our capabilities and bring further expertise in-house as we continue our growth and development as a public company." Mr. Lutgring brings over two decades of legal and strategic a

    8/18/25 8:30:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    $A
    $EQNR
    $SLI
    Financials

    Live finance-specific insights

    View All

    Smackover Lithium Signs First Binding Customer Offtake Agreement for the South West Arkansas Project

    All figures are in US dollars unless otherwise stated. LEWISVILLE, Ark., March 09, 2026 (GLOBE NEWSWIRE) -- Smackover Lithium, a joint venture ("JV") between Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLI) (NYSE.A: SLI) and Equinor, through subsidiaries of Equinor ASA, announced the signing of its first commercial offtake agreement for the South West Arkansas Project ("SWA Project" or the "Project") with Trafigura Trading LLC ("Trafigura"). Trafigura is a market leader in the global commodities industry, with an established presence across battery metals markets including lithium. Under the terms of this binding take-or-pay offtake agreement (the "Agreement"), the

    3/9/26 3:00:00 AM ET
    $SLI
    Major Chemicals
    Industrials

    Agilent Reports First-Quarter Fiscal Year 2026 Financial Results

    Delivers solid Q1 results, raises FY26 reported revenue outlook and increases non-GAAP EPS(3) guidance while confirming core-revenue growth(1) and margin expansion First-quarter fiscal year 2026 Revenue of $1.80 billion for the first quarter ended Jan. 31, 2026, representing growth of 7.0% reported and up 4.4% on a core(1) basis compared with the first quarter of 2025. GAAP net income of $305 million; earnings per share (EPS) of $1.07, a decline of 4% from the first quarter of 2025. Non-GAAP(2) net income of $386 million; non-GAAP EPS(3) of $1.36, growing 4% from the first quarter of 2025. Fiscal year 2026 and second-quarter outlook Fiscal year 2026 revenue is expected in t

    2/25/26 4:05:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Equinor ASA: Announcement of cash dividend of NOK 3.5249 per share for third quarter 2025

    Equinor ASA ((OSE: EQNR, NYSE:EQNR) announced on 29 October 2025 a cash dividend per share of USD 0.37 for third quarter 2025. The NOK cash dividend per share is based on average USDNOK fixing rate from Norges Bank in the period plus/minus three business days from record date 17 February 2026, in total seven business days. Average Norges Bank fixing rate for this period was 9.5267. Total cash dividend for third quarter 2025 is consequently NOK 3.5249 per share. On 27 February 2026, the cash dividend will be paid to relevant shareholders on Oslo Børs (Oslo Stock Exchange) and to holders of American Depositary Receipts ("ADRs") on New York Stock Exchange. This information is published in a

    2/23/26 1:50:00 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    $A
    $EQNR
    $SLI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials